Advertisement
Screener

Siga Technologies INC (SIGA) Income (Loss) from Continuing Operations before Income Taxes, Domestic

1.6 / 5 stars · 32/98 Roast Me

Siga Technologies INC Income (Loss) from Continuing Operations before Income Taxes, Domestic

Siga Technologies INC (SIGA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $30.33 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Income Statement › Pre-tax Income

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-10

  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2017-09-30 was $9.70M, a 5.43% increase year-over-year.
  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2017-06-30 was $7.40M, a 22.92% decline year-over-year.
  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2017-03-31 was $8.50M, a 18.27% decline year-over-year.
  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for the quarter ending 2016-09-30 was $9.20M, a 64.29% increase year-over-year.
  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $30.33M, a 60.11% decline from fiscal 2024.
  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $76.04M, a 13.30% decline from fiscal 2023.
  • Siga Technologies INC income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $87.70M.
Period endIncome (Loss) from Continuing Operations before Income Taxes, Domestic 3 monthIncome (Loss) from Continuing Operations before Income Taxes, Domestic 6 monthIncome (Loss) from Continuing Operations before Income Taxes, Domestic 9 monthIncome (Loss) from Continuing Operations before Income Taxes, Domestic 12 month
2025-12-31$30.33M
10-K · filed 2026-03-10
2024-12-31$76.04M
10-K · filed 2026-03-10
2023-12-31$87.70M
10-K · filed 2026-03-10
2017-09-30$9.70M
10-Q · filed 2017-11-07
$17.10M
derived: sum of 2 quarters · filed 2017-11-07
$25.60M
10-Q · filed 2017-11-07
2017-06-30$7.40M
10-Q · filed 2017-08-03
$15.90M
10-Q · filed 2017-08-03
2017-03-31$8.50M
10-Q · filed 2017-05-04
2016-09-30$9.20M
10-Q · filed 2016-11-02
$18.80M
derived: sum of 2 quarters · filed 2016-11-02
$29.20M
10-Q · filed 2016-11-02
2016-06-30$9.60M
10-Q · filed 2016-08-08
$20.00M
10-Q · filed 2016-08-08
2016-03-31$10.40M
10-Q · filed 2016-05-04
2015-09-30$5.60M
10-Q · filed 2015-10-27
$12.10M
derived: sum of 2 quarters · filed 2015-10-27
$19.10M
10-Q · filed 2015-10-27
2015-06-30$6.50M
10-Q · filed 2015-08-04
$13.60M
10-Q · filed 2015-08-04
2015-03-31$7.10M
10-Q · filed 2015-05-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B